Latest Breaking News On - தாமஸ் நெஸ்டல்பெர்கர் - Page 1 : comparemela.com

April 23, 2021 The hunt continues for a simple lab test that might help clinicians expeditiously sort out which type of MI is afflicting patients who present to the emergency department with chest pain, so as to streamline care. The latest effort, which evaluated 17 novel CV biomarkers, failed to uncover any that offered much in the way of help. None was significantly better at discriminating between type 1 and type 2 MI when compared with troponins measured using high-sensitivity assays, which themselves have only modest diagnostic value for this purpose, Thomas Nestelberger, MD (Vancouver General Hospital, Canada, and University Hospital Basel, Switzerland), and colleagues report in a study published online April 21, 2021, ahead of print in

United statesThomas nestelbergerMarc sabatineUniversity hospital baselVancouver general hospitalAdvantageous predictorsAcute coronary syndromes evaluationFourth universal definitionஒன்றுபட்டது மாநிலங்களில்தாமஸ் நெஸ்டல்பெர்கர்பல்கலைக்கழகம் மருத்துவமனை பேசல்வான்கூவர் ஜநரல் மருத்துவமனைநான்காவது உலகளாவிய வரையறை